EU Tissue Product Approval Should Be Distinct From Devices - EC Cmte.
This article was originally published in The Gray Sheet
Executive Summary
Approval and regulation of tissue-engineered products should be separate from the current procedures for medical devices, according to the European Commission's Scientific Committee on Medicinal Products and Medical Devices.
You may also be interested in...
ATS Gives Smith & Nephew Second Skin; Wound Treatment Portfolio Elevated
Smith & Nephew's joint venture with Advanced Tissue Sciences to develop and market Dermagraft bio-engineered skin will be a major driver of S&N growth over the next five years, the British firm anticipates
ATS Gives Smith & Nephew Second Skin; Wound Treatment Portfolio Elevated
Smith & Nephew's joint venture with Advanced Tissue Sciences to develop and market Dermagraft bio-engineered skin will be a major driver of S&N growth over the next five years, the British firm anticipates
Tissue Product Premarket Route, Legal Framework Debated By EU Regulators
The submission of European tissue product premarket filings to a "central expert body" comprising member state representatives is one of various review options explored by the European Commission in a July consultation document